The onset of the Covid-19 pandemic led to a sea change in dependancy drugs — particularly, elevated entry to buprenorphine, a drug generally used to deal with opioid use dysfunction.
Now, new knowledge present that regardless of the medicine’s wider availability, deaths involving buprenorphine nonetheless represent a small fraction of total drug mortality.
The research, revealed Friday in JAMA Community Open, presents new perception into the influence of emergency insurance policies enacted in early 2020 to gradual Covid’s unfold whereas preserving entry to dependancy care. The modifications allowed medical doctors to problem new buprenorphine prescriptions by way of telemedicine, making the medicine much more accessible for sufferers in rural areas or with out entry to transportation.
Buprenorphine, nevertheless, is itself an opioid, and is regulated as a managed substance. Whereas most medical doctors and well being officers welcomed the modifications, a small minority expressed concern that growing buprenorphine entry may have unintended penalties.
These issues have been largely unfounded, in keeping with the brand new analysis, which was authored by prime dependancy researchers on the Facilities for Illness Management and Prevention and the Nationwide Institute on Drug Abuse.
Whereas deaths involving buprenorphine did tick upward within the months following the coverage modifications, they elevated at a considerably decrease charge than total drug deaths. Between July 2019 and June 2021, the share of opioid-related deaths involving buprenorphine dropped from 3.6% to 2.1%.
Amongst those that died of buprenorphine-involved overdoses, simply 20% have been particularly receiving drugs used to deal with opioid use dysfunction, that means the drug was possible acquired illegally.
Extra broadly, almost 93% of deaths involving buprenorphine additionally concerned different substances, that means that fewer than 1 in 600 opioid-involved deaths is attributable to buprenorphine alone.
The examine’s publication comes amid a broader motion to extend entry to dependancy drugs. In December, Congress handed laws eliminating a requirement that medical doctors wishing to prescribe the medicine receive a particular license generally known as an “X-waiver.”
Federal regulators additionally introduced plans to make the emergency telehealth provisions enacted in 2020 everlasting. As well as, Covid-era guidelines permitting sufferers to take dwelling weeks’ value of methadone, one other widespread and extremely efficient remedy for opioid dependancy, will even grow to be everlasting. An analogous examine revealed final yr confirmed that methadone-related deaths didn’t enhance regardless of the brand new flexibilities.
Nonetheless, entry to buprenorphine shouldn’t be with out its challenges. Some pharmacies have reported that the Drug Enforcement Administration nonetheless conducts raids on services filling telemedicine prescriptions for buprenorphine, regardless of the brand new guidelines.
Individually, medical doctors throughout the U.S. have reported elevated problem with buprenorphine “inductions,” or the method of giving sufferers their first dose. Because the drug provide has grow to be extra contaminated by fentanyl, buprenorphine has grow to be extra more likely to trigger extreme withdrawal signs, main sufferers to hunt remedy utilizing options like methadone — or keep away from remedy altogether.
STAT’s protection of power well being points is supported by a grant from Bloomberg Philanthropies. Our monetary supporters should not concerned in any selections about our journalism.
Get your day by day dose of well being and drugs each weekday with STAT’s free e-newsletter Morning Rounds. Enroll right here.